Publications by authors named "Sonja Nick"

Claim this Profile
F
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.
Xiaohua Wu, Jihong Liu, Ruifang An, Rutie Yin, Yu Zhang, Sonja Nick

J Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study.
Simon Rule, Wolney Gois Barreto, Javier Briones, Angelo M Carella, Olivier Casasnovas, Sonja Nick

Haematologica· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors.
Amit M Oza, François Dubois, Roberto Hegg, Carlos Alberto Hernández, Gaetano Finocchiaro, Sonja Nick

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
Jorge E Cortes, Hagop M Kantarjian, Michael J Mauro, Fiona An, Sonja Nick

Eur J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Martin Kuentz, Sonja Nick, Neil Parrott, Dieter Röthlisberger

Eur J Pharm Sci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis